Covid-19

The COVID Drug That’s Better Than Paxlovid Is Finally Here. Why You Haven’t Heard About It.

Xocova (ensitrelvir) is a superior COVID antiviral with fewer side effects and no rebound, approved in Japan since 2023. It’s finally available in the US โ€” but the system that rushed Paxlovid now blocks this better option. Here’s why you need to know about it.